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Janus-faced Sestrin2 controls ROS and mTOR
signalling through two separate functional domains
Hanseong Kim1,*, Sojin An1,*, Seung-Hyun Ro2,*,w, Filipa Teixeira3,4,5,6, Gyeong Jin Park1,7, Cheal Kim7,
Chun-Seok Cho2, Jeong-Sig Kim2,8, Ursula Jakob1,3, Jun Hee Lee2 & Uhn-Soo Cho1

Sestrins are stress-inducible metabolic regulators with two seemingly unrelated but
physiologically important functions: reduction of reactive oxygen species (ROS) and inhibition
of the mechanistic target of rapamycin complex 1 (mTORC1). How Sestrins fulﬁl this dual role
has remained elusive so far. Here we report the crystal structure of human Sestrin2 (hSesn2),
and show that hSesn2 is twofold pseudo-symmetric with two globular subdomains, which are
structurally similar but functionally distinct from each other. While the N-terminal domain
(Sesn-A) reduces alkylhydroperoxide radicals through its helix–turn–helix oxidoreductase
motif, the C-terminal domain (Sesn-C) modiﬁed this motif to accommodate physical
interaction with GATOR2 and subsequent inhibition of mTORC1. These ﬁndings clarify the
molecular mechanism of how Sestrins can attenuate degenerative processes such as aging
and diabetes by acting as a simultaneous inhibitor of ROS accumulation and mTORC1 activation.
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estrins are a family of stress-inducible metabolic regulators1
that are conserved throughout the metazoan species.
Cell-based studies showed that Sestrins have an
antioxidant function that suppresses reactive oxygen species
(ROS)2. In addition to its antioxidant activity, Sestrins activate
AMP-activated protein kinase (AMPK) and subsequently
inhibit mechanistic target of rapamycin (mTOR) complex 1
(mTORC1)3. Genetic studies of Drosophila Sestrin (dSesn)
revealed that dSesn also functions as a critical negative feedback
regulator of dTORC1 (ref. 4). Depletion of dSesn downregulates
AMPK and upregulates dTORC1, which together lead to the
accelerated development of several age-related and obesityinduced pathologies, such as lipid accumulation, mitochondrial
dysfunction, protein aggregate formation, cardiac arrhythmia and
muscle degeneration4. These pathologies are very reminiscent of
age-associated human diseases, which are promoted by obesity.
Importantly, most of the observed pathologies were suppressed by
administration of AMPK activators, mTORC1 inhibitors or
antioxidants4, indicating that the mTORC1- and ROS-controlling
functions of Sestrin are indeed important for its physiological
functions. Similar age-associated metabolic defects were also
observed in cSesn-mutated Caenorhabditis elegans5, suggesting
that the physiological roles of Sestrin-family proteins are
evolutionarily conserved.
Indeed, Sestrins in mammals also play an important
metabolism-regulating role. Recent studies indicate that mouse
Sestrins are important for attenuating obesity-associated
metabolic liver pathologies such as insulin resistance and
steatohepatitis through oxidative stress suppression6 or AMPK
activation, mTORC1 inhibition and subsequent mTORC2
potentiation7–9. Also in other tissues such as lungs10,11,
kidneys12, neurons13–15, macrophages16, as well as embryonic
ﬁbroblasts17, mammalian Sestrins are important for proper
regulation of ROS or mTORC1 signalling.
Although it is clear that Sestrins are critical for ROS- and
mTOR-associated metabolic homeostasis, we still do not have a
clear biochemical understanding of how a single protein can
perform such a diverse set of physiological roles, crucially
important for metabolic homeostasis and aging prevention. This
is mostly due to the complete lack of structural information about
Sestrins. Here we report the crystal structure of human Sestrin2
(hSesn2) for the ﬁrst time. The structure of hSesn2 displays an
interesting internal symmetry with two homologous subdomains
(Sesn-A and Sesn-C), which have a similar structure but distinct
functions. Sesn-A functions as an alkylhydroperoxide reductase,
while Sesn-C performs an mTORC1-inhibiting role. Through
these two independent domains, Sestrin can single-handedly
suppress both ROS and mTORC1, which are well-established
promoters of aging and age-associated pathologies18.
Therefore, our discovery provides an explanation for how a
single protein can play such a versatile anti-aging role, especially
considering that excessive ROS accumulation and chronic
mTORC1 activation are well-known facilitators of aging and
age-associated diseases.

S

Results
Structural determination of full-length hSesn2 protein. To gain
insights into the biochemical and structural properties of Sestrins,
we determined the crystal structure of full-length hSesn2 at 3.5-Å
resolution (Fig. 1a and Table 1). The electron density map of
hSesn2 was calculated using the single-wavelength anomalous
diffraction (SAD) method with selenomethionine (SeMet)substituted proteins. Despite its low-resolution diffraction,
we were able to obtain a high-quality electron density map by
taking advantage of non-crystallographic symmetry averaging
2
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Figure 1 | Crystal structure of full-length hSesn2. (a) Ribbon diagram of
full-length hSesn2. Sesn-A, Sesn-B and Sesn-C domains are in slate, pink
and green, respectively. hSesn2 is composed of two globin-like a-helix-only
domains (Sesn-A and Sesn-C) connected by a helix–loop–helix domain
(Sesn-B) with a total of 23 helices. The overall structure is well-deﬁned
except for residues 1–65, 221–224, 240–255, 272–279, 295–307, 329–332
and 479–480. Key residues (C125, D406 and D407) in each of the globular
domains are displayed in a stick model, indicated by red arrows.
(b) Schematic diagram of domain organization of hSesn2. Illustrations of
the protein structure used in all ﬁgures were generated with either PYMOL
(Delano Scientiﬁc, LLC) or Chimera (UCSF chimera). The relative locations
of C125, D406 and D407 are marked in red.

(ﬁve copies of hSesn2 per asymmetric unit (ASU)) and the high
solvent content (68%) (Supplementary Fig. 1). Furthermore, the
helix-dominant structure and appropriately located selenium
positions (total 12 sites per monomer) allowed us to precisely
place the sequence in the electron density map. The ﬁnal reﬁned
model of hSesn2 shows an R/Rfree of 24.3/26.9.
Overall structure of hSesn2 protein. The crystal structure
revealed that hSesn2 belongs to the family of globin-like a-helixfold proteins, consisting of 23 helices and no b-sheets (Fig. 1a and
Supplementary Fig. 2a,c). The structure of full-length hSesn2
indicates that the protein contains three domains separated by
two unstructured ﬂexible linker regions (Fig. 1b). These three
domains correspond well to the Sesn-A, Sesn-B and Sesn-C
domains, which have been previously identiﬁed through a
phylogenetic analysis19. Both Sesn-A and Sesn-C domains of
hSesn2 form a globular shape, which is noticeably similar to each
other (Figs 1a and 2a). Indeed, the Ca r.m.s. difference between
Sesn-A and Sesn-C turned out to be only 1.95 Å (total 110
residues compared). Although Sesn-B was originally predicted
to have a coiled coil motif (Supplementary Fig. 3), it forms a
helix–loop–helix structure and lies on the surface of Sesn-C
(Fig. 1a). hSesn2 appears to be a monomer, both in its crystal
structure (Supplementary Fig. 1b) as well as in its analysis using
size-exclusion chromatography combined with multi-angle light
scattering (Supplementary Fig. 4).
Structural similarity between Sesn-A and oxidoreductases.
To infer the function of hSesn2 based on its three-dimensional
structure, we searched for proteins structurally related to hSesn2
using a distance-matrix alignment programme (Dali server)20.
The top ranked result revealed that both Sesn-A and Sesn-C
possess a high degree of structural similarity with an
uncharacterized protein YP_296737.1 (PDB ID: 2PRR) in
Ralstonia eutropha JMP134 (Fig. 2a and Supplementary
Fig. 5a). Interestingly, the Sesn-A and Sesn-C domains in the
full-length hSesn2 protein overlap with the dimer structure of

NATURE COMMUNICATIONS | 6:10025 | DOI: 10.1038/ncomms10025 | www.nature.com/naturecommunications

ARTICLE

NATURE COMMUNICATIONS | DOI: 10.1038/ncomms10025

Table 1 | Data collection and reﬁnement statistics for SAD
(SeMet) structure.
hSesn2–SeMet
Data collection
Space group
Cell dimensions
a, b, c (Å)
a, b, g (°)
Resolution (Å)
Rmerge
Rpim
I/sI
Completeness (%)
Redundancy
CC1/2 (%)
Reﬁnement
Resolution (Å)
No. of reﬂections
Rwork/Rfree
No. of atoms
Protein
Ligand/ion
Water
B-factors
Protein
Ligand/ion
Water
R.m.s deviations
Bond lengths (Å)
Bond angles (°)
Ramachandran plot stats (%)
Favoured
Allowed
Disallowed

I23
292.7
90
44.1–3.5 (3.59–3.50)*
0.305 (2.201)
0.046 (0.335)
28.5 (3.7)
99.9 (100)
88.6 (86.2)
99.9 (87.8)

44.1–3.5
49798
0.243 / 0.269
15028

94.7

0.0099
1.5071
94.0
6.0
0.0

SAD, single-wavelength anomalous diffraction.
*Highest resolution shell is shown in parenthesis.

YP_296737.1 (Supplementary Fig. 6), suggesting that the
monomer of YP_296737.1 has been duplicated in hSesn2, and
divergently evolved into two domains in a single polypeptide.
YP_296737.1 was predicted as a putative alkylhydroperoxidase21. Despite barely conserved primary sequences
(Supplementary Fig. 5b), we noted that 109–139 amino acids of
the Sesn-A domain show a very distant sequence homology
to YP_296737.1 as well as to AhpD, a well-characterized
alkylhydroperoxidase in Mycobacterium tuberculosis21–23, as
formerly reported2. The homology region corresponds to the
helix–turn–helix motif of AhpD, a signature motif found in the
family of AhpD-like oxidoreductases21–23. The relative position
of the motif within the primary sequence is similar between
hSesn2 and YP_296737.1 but different in AhpD (Supplementary
Fig. 5a). Interestingly, whereas both YP_296737.1 and AhpD are
characterized by a catalytic cysteine dyad (Cys86 and Cys89 in
YP_296737.1), the Sesn-A domain contains only the ﬁrst cysteine
(Cys125 in hSesn2) with the second cysteine being substituted for
a leucine (Leu128 in hSesn2) (Fig. 2b). Nevertheless, other
catalytically important residues proposed to mediate the proton
relay system in AhpD23, are well-conserved in the Sesn-A domain
(Tyr127, His132 and His113) as well as in YP_296737.1 (Tyr88,
His93 and Glu74) (Fig. 2b and Supplementary Fig. 5b).
Sesn-A functions as an alkylhydroperoxide reductase. To
investigate whether hSesn2 is indeed a functional antioxidant
enzyme in vitro, we tested its ROS-detoxifying activities using
different substrates. Even though AhpD is able to reduce

hydrogen peroxide24, hSesn2 did not exhibit any detectable
reducing activities towards hydrogen peroxide (Fig. 3a). However,
cumene hydroperoxide, an alkylhydroperoxide with a bulky
hydrophobic group24, was efﬁciently reduced by hSesn2, as
shown by two independent biochemical assays involving
quantiﬁcation of reduced alkylhydroperoxides (Fig. 3b) or
oxidized dithiothreitol (Fig. 3c). These results suggest that
hSesn2 is an active alkylhydroperoxide-detoxifying enzyme.
Mutation of Cys125 (C125S)—the only catalytic cysteine
identiﬁed in the putative active site of hSesn2, His132
(H132A)—the residue critical for the conserved proton relay
system, or Tyr127 (Y127F)—the residue potentially involved in
the catalytic process, reduced this redox activity down to the level
of a redox-active yet peroxidase-inactive control protein (that is,
NemRC106 only)25 (Fig. 3d). The difference between the kcat values
of hSesn2-C125S and NemRC106 only is only B5% of the
difference between hSesn2-WT and NemRC106 only,
demonstrating that Cys125 alone can account for B95% of
alkylhydroperoxidase activity of hSesn2 over the negative control.
However, mutations of other surface-exposed cysteines did not
abolish the alkylhydroperoxidase activity of hSesn2 (Fig. 3d).
These results suggest that the helix–turn–helix motif of the
Sesn-A domain indeed constitutes an active catalytic site as an
oxidoreductase. It is worth noting that Cys125 is surrounded
by hydrophobic molecular surfaces (Supplementary Fig. 7),
which may direct hSesn2’s peroxidase activity speciﬁcally
towards hydrophobic alkylhydroperoxides, such as cumene
hydroperoxide, and reduce the afﬁnity for hydrogen peroxide.
Intriguingly, the kcat value of hSesn2-WT (29.82±2.5 min  1)
is considerably higher than that of M. tuberculosis
AhpC (20.13±1.03 min  1) and AhpD (16.01±2.54 min  1),
suggesting that hSesn2 is a more effective alkylhydroperoxidase
than these bacterial enzymes.
hSesn2 uses cysteine sulfenic acid as a reaction intermediate.
In M. tuberculosis AhpD, the reaction of the active site
cysteine with hydroperoxides leads to the formation of a highly
unstable sulfenic acid, which rapidly interacts with the nearby
cysteine residue to form a stable disulﬁde bond22,23. Since Cys125
in hSesn2 does not contain another cysteine residue in close
vicinity, we predicted that a stable sulfenic acid would be formed
as a reaction intermediate. Indeed, we detected signiﬁcant
cysteine sulfenylation in hSesn2-WT after treatment with
cumene hydroperoxide, but not in a negative control protein
NemRC106 only, known to form a sulfenamide switch instead25
(Fig. 4a). The C125S mutation, but not the mutation of other
cysteines in hSesn2, abolished sulfenic acid formation, conﬁrming
that Cys125 is the main catalytic residue that is oxidized
during reduction of alkylhydroperoxides (Fig. 4b). Analysis of
endogenous hSesn2 immunopuriﬁed from hydroperoxide-treated
RKO cells further demonstrated that hSesn2 undergoes
substantial sulfenylation during oxidative stress in vivo
(Fig. 4c,d). Collectively, these results show that hSesn2 reduces
alkylhydroperoxide radicals using single catalytic cysteine
(Cys125), which is reversibly sulfenylated during its catalytic
cycle (Fig. 4e).
Helix–turn–helix motif is not conserved in Sesn-C. Sesn-C
also displays structural resemblance to YP_296737.1/Sesn-A
(Fig. 2a). However, a major difference was detected at the
helix–turn–helix motif (Fig. 2b), which is the signature motif in
the YP_296737.1/Sesn-A/AhpD structure (Supplementary
Fig. 5a). None of the catalytic residues involved in AhpD
oxidoreductase activity23 are present in the corresponding region
of Sesn-C (Fig. 2b). Furthermore, the helix–turn–helix motif is
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Figure 2 | hSesn2 subdomains (Sesn-A/Sesn-C) have a structural similarity to YP_296737.1. (a) Structural overlay between Sesn-A (slate), Sesn-C
(green) and monomeric R. eutropha YP_296737.1 (cyan). The overall architectures of Sesn-A, Sesn-C and YP_296737.1 are structurally similar to each
other with r.m.s. differences of 1.95 Å (Sesn-A versus Sesn-C, total 110 residues compared), 1.94 Å (Sesn-A versus YP_296737.1, 139 residues) and 2.32 Å
(Sesn-C versus YP_296737.1, 104 residues). From this study, we identiﬁed two functionally active sites in each of Sesn-A and Sesn-C domains, which are
highlighted in pink. (b) Structure comparison of the highlighted regions in a, which corresponds to the helix–turn–helix oxidoreductase motif of
YP_296737.1. Only one cysteine is preserved in Sesn-A (Cys125), and none are found in Sesn-C.
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(n ¼ 3, mean±s.e.m.). P values were calculated using the Student’s t-test. NS, non-signiﬁcant (P40.05). (b) From the FOX assay, hSesn2 shows signiﬁcant
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are presented as a bar graph (n ¼ 3, mean±s.e.m.). P values were calculated using the Student’s t-test. (c) Dithiothreitol (DTT)-dependent
alkylhydroperoxidase activity of hSesn2 (WT and C125S mutant) towards cumene hydroperoxide was measured at 310 nm. (d) The kcat of hSesn2-WT,
NemRC106 only (negative control, white), M. tuberculosis AhpC/AhpD (blue), and hSesn2-WT and hSesn2-mutants was presented as a bar graph
(n ¼ 3, mean±s.e.m.).

replaced by a helix–loop structure in Sesn-C, strongly suggesting
that Sesn-C may have lost its antioxidant function
during evolution, even though the overall architecture is still
maintained. The sequence of Sesn-C is, however, very strictly
4

conserved across the Sestrin family (Supplementary Fig. 2a,b),
suggesting that, during evolution, Sesn-C may have acquired
another important functional role that is independent of the
antioxidant function.
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Sesn-C is responsible for mTORC1 inhibition. To understand
the regulatory function of hSesn2 towards mTORC1 inactivation,
we introduced a series of structure-guided mutations in hSesn2
(Supplementary Table 1), including mutations in all the evolutionarily conserved surface residues of Sesn-C (Fig. 5a). To test
how these mutations affect the mTORC1-suppressing activity of
hSesn2, we monitored mTORC1-dependent phosphorylation of
p70 S6 kinase (S6K) through a phosphorylation-induced gel shift
assay26. All the hSesn2 constructs except the R404A/D406A/
D407A (hereafter, RDD) mutant maintained their strong
suppression of mTORC1, as shown by inhibition of S6K shifts
(Fig. 5b,c). The RDD mutation impaired mTORC1-inhibiting
activity of hSesn2 in HEK293 (Fig. 5c) and RKO cells (Fig. 5d), as
monitored by phosphorylation of mTORC1 downstream proteins
such as S6K, S6 and 4E-binding protein (4E-BP). Further analysis
of individual mutations within RDD conﬁrmed that both D406A
and D407A mutations, but not R404A, abolished the mTORC1suppressing activity of hSesn2 (Fig. 6a,b and Supplementary
Fig. 8a), suggesting that Asp406 and Asp407 (hereafter, the DD
motif) play the key role in mTORC1 inhibition. Mutations in
the DD motif also prevented hSesn2 from inducing AMPK
activation (Fig. 6b), which partially contributes to the mTORC1
suppression3,27. Interestingly, these two residues are located in
the putative active site of Sesn-C (the helix–loop motif, Fig. 2b),
indicating that Sesn-C may have acquired the mTORC1regulating function by modifying the ancestral active site of an
alkylhydroxyperoxidase during evolution. The C125S, H132A and
Y127F mutations, which abrogate oxidoreductase activity of

hSesn2 (Fig. 3d), did not disrupt the mTORC1-suppressing
function of hSesn2 (Fig. 5b,d) and the DD motif mutations did
not interfere with the oxidoreductase activity of hSesn2 (Fig. 3d).
These results demonstrate that hSesn2 has two functional sites in
separate domains (Sesn-A and Sesn-C), which independently
regulate ROS levels and mTORC1 signalling. This unique feature
makes the hSesn2 structure conceptually resemble the face of
Janus—a twofold pseudo-symmetric molecule exhibiting two very
distinct characteristics from its diametric domains (Fig. 6c).
hSesn2 is not a structural homologue of human GDI1. hSesn2
was recently suggested to serve as a guanosine nucleotide
dissociation inhibitor (GDI) for Rag GTPases17. This hypothesis
was based on a very limited sequence homology between hSesn2
and human GDI1 (hGDI1)17. The overall structure of hGDI1
(PDB ID: 1UKV) is, however, very different from that of hSesn2
(Supplementary Fig. 9a). The putative GDI motif in hSesn2 also
does not show any structural resemblance with the corresponding
region in hGDI1 as shown in Supplementary Fig. 9b. Suggested
key residues in the proposed GDI motif, such as Lys422 and
Lys426 in hSesn2, are buried inside the structure, while another
key residue Arg419 is surface exposed (Supplementary Fig. 9b,c).
Mutation of these residues (R419A or R419A/K422A/K426A) did
not abolish mTORC1-inhibiting function of hSesn2 (Fig. 5c),
suggesting that the DD motif, not the putative GDI motif
proposed by the former study17, constitutes the functional site
responsible for mTORC1 inhibition.
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Figure 5 | Arg404/Asp406/Asp407 residues in Sesn-C constitute a functional site for mTORC1 regulation. (a) The surface of Sesn-C was
subdivided into ﬁve different areas (highlighted in blue, purple, yellow, green and red) that contain the most highly conserved surface residues. In addition,
the residues corresponding to the formerly described putative GDI motif (Arg419, Lys422 and Lys426)17 are highlighted in brown. These residues were
mutated into alanines as described in Supplementary Table S1. (b,c) The R404A/D406A/D407A mutation (highlighted in yellow), but none of the
other mutations, abolished the mTORC1-inhibiting activity of hSesn2. mTORC1-dependent phosphorylation of S6K was monitored by electromobility
retardation of HA–S6K (shifted bands)26. HEK293 cells were transfected with plasmid constructs expressing HA-tagged S6K1 and Flag-tagged hSesn2 of
the indicated mutations. GFP or an empty vector (S6K1 only) was used as negative controls. After 48 h of transfection, cell lysates were analysed by
immunoblotting of the indicated proteins. (d) RKO cells were infected with lentiviral constructs expressing GFP or Flag-tagged hSesn2 of indicated
mutations. After 48 h of infection, cell lysates were analysed by immunoblotting of the indicated proteins. Rapamycin (rap, 100 nM for 24 h) was used as a
positive control for mTORC1 inhibition. Molecular weight markers are indicated in kDa.

The DD motif is critical for hSesn2–GATOR2 association.
According to the other recent reports27–29, hSesn2 controls
mTORC1 activity through modulation of the GATOR1–
GATOR2 complexes. The GATOR1 complex, which contains
NPRL2, NPRL3 and DEPDC5, functions as a GTPase-activating
protein (GAP) for Rag GTPase and thereby inhibits the
localization of mTORC1 at lysosomes30. The GATOR2
complex, composed of WDR24, WDR59, SEC13, SEH1L and
MIOS, blocks the GAP activity of GATOR1 and thereby
potentiates mTORC1 activation30. hSesn2 directly binds to the
GATOR2 complex and liberates GATOR1 from GATOR2mediated inhibition, leading to mTORC1 inactivation27–29.
Although we did not detect the direct interaction between
hSesn2 and Rag GTPases (Supplementary Fig. 9d-f), we
conﬁrmed that hSesn2 exhibits a strong physical interaction
with GATOR2 in vivo (Fig. 6d and Supplementary Fig. 9f) and
in vitro (Fig. 6e), consistent with these studies27–29. Based on our
structural and cell biological results, we reasoned that the helix–
loop structure of Sesn-C might provide the surface for a protein–
protein interaction particularly between hSesn2 and GATOR2.
To test this idea, we examined the physical interactions between
GATOR2 and hSesn2 variants, including WT, C125S, RDD and
individual R404A, D406A and D407A mutants of hSesn2.
Our co-immunoprecipitation analysis revealed that hSesn2-WT,
as well as hSesn2-C125S and hSesn2-R404A, interact well with
GATOR2; however, the RDD mutation, as well as individual
D406A and D407A mutations, almost completely abolished the
6

physical interaction between hSesn2 and GATOR2 (Fig. 6d,e and
Supplementary Fig. 8b,c), suggesting that the DD motif in the
helix–loop region of Sesn-C (Fig. 2b) are indeed critical for
physical interaction with the GATOR2 complex and subsequent
modulation of mTORC1 signalling (Fig. 6c).
Discussion
Although the physiological signiﬁcance of Sestrin proteins has
been well-documented, the biochemical and functional understanding of this protein family has been very limited mostly due
to the absence of knowledge about its structure. Here we present
the crystal structure of full-length hSesn2, as the ﬁrst molecular
portrait for the Sestrin-family proteins. The crystal structure of
hSesn2 reveals two structurally similar subdomains (Sesn-A
and Sesn-C), whose biological functions have developed
differently during evolution, with an antioxidant function and
an mTORC1-inhibitory function, respectively.
Although a number of studies indicate that hSesn2 is an
important cellular suppressor of ROS2,6,13,15,16,31–34, there has
been tremendous controversy over whether hSesn2 indeed
possesses oxidoreductase activity. This is because the originally
proposed catalytic activity of hSesn2 as an ATP-dependent
sulﬁnic acid reductase2 was not detectable in follow-up
studies35,36. From our hSesn2 structure, we were also unable to
detect any structural similarity between hSesn2 and
sulﬁredoxin37, the only known cysteine sulﬁnic acid
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NATURE COMMUNICATIONS | 6:10025 | DOI: 10.1038/ncomms10025 | www.nature.com/naturecommunications

7

ARTICLE

NATURE COMMUNICATIONS | DOI: 10.1038/ncomms10025

reductase38,39. However, the crystal structure of hSesn2 revealed
that both Sesn-A and Sesn-C domains of hSesn2 bear the
structural resemblance with R. eutropha YP_296737.1, which
belongs to a family of alkylhydroperoxidases including
M. tuberculosis AhpD21. Sequence alignment suggested that
Sesn-A and YP_296737.1, but not Sesn-C, possess a limited
sequence similarity with the catalytic active site sequence of
M. tuberculosis AhpD (Supplementary Fig. 5b), as initially
reported2. The conserved regions in all three proteins exhibit
the helix–turn–helix oxidoreductase motif21, although the relative
position of the oxidoreductase motif within their primary
sequence is different between AhpD and Sesn-A/YP_296737.1
(Supplementary Fig. 5a). The catalytic cysteine (Cys125)
and residues in the proton delay system of AhpD-family
oxidoreductases (Tyr127 and His132) are well-preserved within
the Sesn-A domain21.
Based on the structural similarity with bacterial alkylhydroxyperoxidases, we predicted that Sesn-A may function as a direct
scavenger for ROS. In particular, we reasoned that potential
substrates of hSesn2 might be hydrophobic ROS because
hydrophobic surface residues surround the active site of Sesn-A
(Supplementary Fig. 7). Indeed, hSesn2 was able to efﬁciently
eliminate bulky hydrophobic ROS (that is, cumene hydroperoxide), but not small hydrophilic ROS (that is, hydrogen
peroxide) (Fig. 3). Mutations of the key catalytic residues in the
helix–turn–helix oxidoreductase motif of Sesn-A (Fig. 2b), such
as Cys125, Tyr127 and His132, abolished the catalytic activity of
hSesn2 as an alkylhydroperoxidase (Fig. 3), indicating that this
motif is indeed responsible for Sesn-A’s catalytic activity.
Considering that genetic loss of Sestrins can provoke diverse
age- and obesity-associated pathologies such as type II diabetes,
neurodegeneration and cardiovascular diseases4,7,9,40–42, one of
the possible physiological substrates for hSesn2 is lipid peroxides,
which are a family of hydrophobic alkylhydroperoxides known to
promote the pathogenesis of these diseases43–46. The complete
redox cycle of Sestrins, including its physiological substrates and
reducing partners, awaits further investigation.
Although Sesn-C is structurally similar to Sesn-A and
YP_296737.1, the helix–turn–helix oxidoreductase motif is not
conserved in Sesn-C. Instead, Sesn-C has a helix–loop structure
with the DD motif (Fig. 2b). Interestingly, the overall sequence of
Sesn-C, including the helix–loop structure and other surface
residues, is highly conserved across all Sestrin-family proteins
(Supplementary Fig. 2a,b). Considering that the mTORC1suppressing function of hSesn2 is independent of its redoxregulating function, we reasoned that Sesn-C might have acquired
a new function as an mTORC1 inhibitor while having lost its
ancient redox activity. To test this possibility, we introduced a
series of mutations on the conserved surface of Sesn-C and
looked for the mutant that abrogates its mTORC1-inhibitory
function (Fig. 5a-c). Although most point mutations in the SesnC domain, including the formerly reported mutations in the
putative GDI motif17, did not affect the mTORC1-inhibiting
function of hSesn2 (Fig. 5b,c), the DD motif was critical for the
mTORC1-inhibitory function of hSesn2. Because mutations of
Cys125/Tyr127/His132 do not affect hSesn2’s mTORC1inhibiting function (Fig. 5b,c) and mutations of the DD motif
do not affect hSesn2’s oxidoreductase function (Fig. 3d), the
function of Sesn-A and Sesn-C domains appears to be
independent from each other. However, it should be further
investigated whether the activities of the two domains exhibit any
cross-talk in some cellular contexts. For example, the mTORC1inhibiting and autophagy-activating functions of Sesn-C can alter
the cellular redox status by indirectly promoting the activity of an
antioxidant transcription factor Nrf2 (ref. 47). In addition, the
role for Sesn-B domain also needs to be clariﬁed. Because of its
8

close proximity to the DD motif (Fig. 1a), Sesn-B may be involved
in the regulation of the activity of Sesn-C in controlling mTORC1.
To explain how hSesn2 inhibits mTORC1, three competing
mechanisms have been proposed in the ﬁeld. (1) The ﬁrst
hypothesis is that hSesn2 inhibits mTORC1 by potentiating
AMPK-mediated activation of TSC2, a Rheb-GAP3. Our data
support this hypothesis by demonstrating that the DD motif in
Sesn-C is required for the AMPK-activating function of hSesn2
(Fig. 6b). Although most literature consistently support that
hSesn2 can provoke AMPK activation4,8,27,40,48–50, hSesn2 is still
able to suppress mTORC1 in AMPK-null cells27–29, suggesting
that there are additional pathways that connect hSesn2 with
mTORC1 inhibition. (2) The second hypothesis is that hSesn2
functions as a GDI for Rag GTPases17. hSesn2 and Rags, however,
do not seem to make a stable complex, as we were unable to
detect a physical interaction between them either in vitro
(Supplementary Fig. 9d.e) or in vivo (Supplementary Fig. 9f).
The crystal structure of hSesn2 does not resemble that of any
known GDIs (Supplementary Fig. 9a), and the putative GDI motif
is in a different geometrical shape in the structure
(Supplementary Fig. 9b). The putative GDI motif was also
dispensable for hSesn2’s mTORC1-inhibitory function (Fig. 5c).
Although it is unlikely that hSesn2 can function as a stand-alone
GDI, it is possible that hSesn2 can control Rag activities through
additional proteins. (3) The third hypothesis is that hSesn2
indirectly regulates Rag GTPase through a physical interaction
with GATOR2 (refs 27–29). GATOR2 is an inhibitor of
GATOR1, a GAP for Rag GTPases. Direct association of
hSesn2 with GATOR2 releases GATOR1 from the GATOR1–
GATOR2 complexes, which triggers the GAP activity of
GATOR1 towards Rag GTPases. In the current study, we have
demonstrated that the DD motif of hSesn2 is critical for the
physical association between hSesn2 and the GATOR2 complex
(Fig. 6d,e and Supplementary Fig. 8b,c). Because the Rag GTPases
serve as a metabolic switch that can reciprocally regulate AMPK
and mTORC1 pathways51 and the GATOR complex is one of the
critical regulators of this switch52,53, hSesn2-mediated inhibition
of GATOR2 and subsequent activation of GATOR1 (refs 27–29)
may be the key signalling event that affects both the AMPK and
mTORC1 signalling pathways.
Through X-ray crystallography and structure-guided molecular
biology experiments, we demonstrate the biochemical and
structural basis of hSesn2’s physiological functions. Janus-faced
hSesn2 reduces alkylhydroperoxide radicals and suppresses
mTORC1 signalling through its two independent functional
motifs that face diametrically opposed directions (Fig. 6c).
Considering that both chronic accumulation of ROS and
prolonged activation of mTORC1 are well-known contributors
to aging and age-associated diseases, these biochemical activities
provide a highly convincing explanation for how Sestrin-family
proteins function as a versatile anti-aging molecule1,19.
Methods
Protein expression and puriﬁcation. The N-terminal 6  histidines and maltosebinding protein (hisMBP)-tagged full-length hSesn2 was expressed in Escherichia
coli Rosetta (DE3) with auto-inducible media54. Cells were harvested and
resuspended in 30 mM Tris-HCl (pH 8.0), 500 mM NaCl and 5 mM
b-mercaptoethanol with protease inhibitor cocktails. After sonication, soluble
protein lysates were obtained from centrifugation at 20,000g for 30 min. The lysates
were then applied into cobalt (Co) afﬁnity chromatography (New England Biolabs)
and eluted with the elution buffer (30 mM Tris-HCl (pH 8.0), 500 mM NaCl,
300 mM imidazole and 5 mM b-mercaptoethanol). The elution fraction was
immediately dialysed against a buffer containing 30 mM Tris-HCl (pH 8.0),
100 mM NaCl and 5 mM b-mercaptoethanol with Tobacco Etch Virus protease
(1:100 ratio) to cleave hisMBP-tag. The dialysed sample was re-applied into the
Co-afﬁnity chromatography to remove hisMBP-tag and the ﬂow-through fraction
was applied into HP Q chromatography (GE healthcare) pre-equilibrated with
30 mM Tris-HCl (pH 8.0), 100 mM NaCl and 1 mM DTT. hSesn2 was eluted by
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gradually increasing salt concentration up to 500 mM NaCl. Fractions that contain
hSesn2 were pooled, concentrated and applied into the Superdex200 (10/300)
size-exclusion chromatography (GE healthcare) pre-equilibrated with 30 mM
Tris-HCl (pH 8.0), 100 mM NaCl and 1 mM TCEP (tris [2-carboxyethyl]
phosphine). SeMet-substituted hSesn2 was expressed with PASM-5052
auto-inducible medium54. All wild-type and mutant proteins of hSesn2, as well
as M. tuberculosis AhpD were cloned, expressed and puriﬁed in the same way.
M. tuberculosis AhpD complementary DNA (MtCD00590021) was obtained
from the DNASU plasmid repository and subcloned into the hisMBP vector.
M. tuberculosis AhpC protein was kindly provided by Dr L.B. Poole (Wake Forest
School of Medicine).
Crystallization and data collection of hSesn2. Crystals of SeMet-substituted
hSesn2 were grown using hanging drop vapour diffusion method at room
temperature by mixing with a reservoir solution of 0.1 M MES (pH 6.5) and 1.15 M
sodium malonate in a 1:1 ratio. Crystals were ﬂash-frozen in liquid nitrogen after
soaking in a cryo-protectant solution consisting of the well solution with 30%
glycerol. SAD data (3.5 Å resolution) of the diamond-shaped crystals, in the space
group I23, a ¼ b ¼ c ¼ 292.7 Å, a ¼ b ¼ g ¼ 90°, were collected in LS-CAT beamline
21-ID-D (Advanced Photon Source, Argonne National Laboratory) at the peak
wavelength of selenium.
Data processing and structure determination of hSesn2. A total of seven SAD
data sets from SeMet-labelled hSesn2 crystals were indexed, integrated, scaled and
merged together by XDS55 through Xia2 (ref. 56). A total of 60 selenium sites from
5 copies of hSesn2 within the ASU were found using SHELXC/D/E57. For phasing,
initial SAD phase was calculated by PHENIX.autosol58. Phases for both
enantiomorphs were generated and the handedness was chosen by visual
inspection of the electron density map. The phase was then subjected to automatic
density modiﬁcation with solvent ﬂattening in the PHENIX programme
RESOLVE59 to improve the phase. High solvent content (68%) and high copy
number of hSesn2 within ASU enabled us to generate an electron density map
whose quality is good enough to visualize all of the helices with mostly
distinguishable side chains (Supplementary Fig. 1a). The a-helix-dominant
structure and 12 SeMet positions within hSesn2 were helpful in assigning the
sequence to the electron density map. The model was manually built using the
programme COOT60 and reﬁnements were carried out using REFMAC5 (ref. 61)
with NCS restraints. The ﬁnal reﬁned model, except for residues 1–65, 221–224,
240–255, 272–279, 295–307, 329–332 and 479–480, contains R/Rfree ¼ 24.3/26.9.
Size-exclusion chromatography with multi-angle light scattering. The average
molecular weight (MW) and hydrodynamic radius (RH) of hSesn2 were determined
by separation using a WTC-050S5 SEC column (Wyatt Technology Corp.) with an
ÄKTAmicro (GE Healthcare) and by analysis with a DAWN HELEOS II MALS
detector equipped with a WyattQELS dynamic light scattering detector and Optilab
rEX differential refractive index detector, using ASTRA VI software (Wyatt
Technology). The Mw was determined from the Raleigh ratio calculated by
measuring the static light scattering and corresponding protein concentration
of a selected peak. Bovine serum albumin served as a calibration standard. For
size-exclusion chromatography with multi-angle light scattering (SEC-MALS),
60 mM hSesn2 were equilibrated in the running buffer (30 mM HEPES (pH 8.0),
100 mM NaCl and 1 mM TCEP) for 20 min on ice.
Measurement of DTT oxidation. WT and mutant hSesn2 proteins, as well as
M. tuberculosis AhpC and AhpD (positive control) and E. coli NemRC106 only
(negative control)25 proteins, puriﬁed as described above, were subjected to a DTT
oxidation assay using cumene hydroperoxides. The rates of DTT oxidation
catalysed by NemRC106 only, M. tuberculosis AhpC/AhpD, hSesn2-WT and
hSesn2-mutants in the presence of cumene hydroperoxide were measured by
monitoring the changes in absorbance at 310 nm due to formation of the DTT
disulﬁde, using a Cary 50 spectrophotometer62. The proteins were initially reduced
by 5 mM DTT, which was then removed by a desalting column (Thermo Scientiﬁc)
before reaction. The assay was initiated by adding 15 mM of cumene
hydroperoxide into a reaction solution containing 10–50 mM of puriﬁed proteins,
5 mM DTT, 1 mM EDTA and 100 mM KPi (pH 7.0), and incubated in a 0.5 ml
quartz cuvette at 25 °C. Each value was corrected for the background oxidation of
DTT by cumene hydroperoxide in the absence of enzymes. The initial rate of DTT
oxidation was obtained by calculating the slope over the ﬁrst 5–10 s after the
addition of cumene hydroperoxide and using the published extinction coefﬁcient of
oxidized DTT (110 M  1cm  1). Three different concentrations between 10 and
50 mM of enzymes were used for the assays, and the initial rates calculated from
these experiments were linearly proportional to the enzyme concentration,
enabling us to calculate kcat values from these independent results.
Measurement of peroxide reduction. The ferrous oxidation–xylenol orange
(FOX) assay63,64 was used to determine the peroxidase activity of hSesn2-WT,
hSesn2-C125S and M. tuberculosis AhpD. Working FOX reagent was freshly
prepared by the addition of 1/100 volume of FOX reagent A (25 mM ammonium

ferrous sulfate in 2.5 M sulfuric acid) into FOX reagent B (100 mM sorbitol and
125 mM xylenol orange). Before peroxidase assay, 10 or 25 mM of proteins were
reduced by 0.1 mM or 0.25 mM DTT in a reaction solution (30 mM HEPES
(pH 7.0), 100 mM NaCl) for hydrogen peroxides or cumene hydroperoxides,
respectively. The reaction was initiated by adding 60 mM of hydrogen peroxides or
150 mM of cumene hydroperoxides into the protein-reaction solution mixture at
room temperature. The concentrations of remaining peroxide were measured at
various time points up to 50 min using the xylenol orange–iron reaction. The
reactions were terminated at 50 min by mixing with 10 volumes of the working
FOX reagent, and the mixtures were further incubated at room temperature for
30 min to allow colour development. The absorbance of the solution was measured
at 560 nm. The peroxide concentrations were calculated by using a freshly prepared
standard curve. All P values were calculated using the Student’s t-test.
Detection of cysteine sulfenic acids. To detect cysteine sulfenic acids of puriﬁed
hSesn2, the proteins were treated with either reducing (1 mM DTT), oxidizing
(120 mM cumene hydroperoxides) or blank agents for 30 min at 37 °C. Cysteine
sulfenic acids were then labelled by 5 mM dimedone at 37 °C for 30 min, and
detected by immunoblotting using a dimedone antibody (a kind gift from
Dr K. Carroll)65. To detect cysteine sulfenic acids of endogenous hSesn2, RKO
human colon cancer cells, cultured as described below, were treated with the
indicated concentrations of cumene hydroperoxides. After thorough washing with
PBS, cells were then lysed in a lysis buffer4 plus 5 mM dimedone for 30 min at
room temperature. Clariﬁed lysates were subjected to immunoprecipitation
using either pre-immune IgG or hSesn2 antibodies as described below. Input
(WCL) and immunopuriﬁed protein complex were analysed by anti-dimedone
immunoblotting of a non-reducing SDS–PAGE gel. For quantiﬁcation of
endogenous hSesn2 sulfenylation, dimedone band intensity was quantiﬁed through
densitometry, normalized to the total immunopuriﬁed hSesn2 levels and expressed
as relative values compared with the untreated levels.
Cell culture, transfection and lentiviral infection. RKO cells are from American
Type Culture Collection (ATCC), and HEK293 cells (293A substrain) are
from Thermo Fisher. Cells were cultured in Dulbecco’s modiﬁed Eagle’s
medium (DMEM, Invitrogen) containing 10% foetal bovine serum and
penicillin/streptomycin at 37 °C in 5% CO2. RKO cells were cultured in low-oxygen
condition (5% O2) for in vivo sulfenylation assays. pLU-CMV–Flag–hSesn2-WT,
pLU-CMV–Flag–hSesn2-C125S, pLU-CMV-GFP2, pRK7–HA–S6K1 (ref. 66),
pRK5-GST–HA–Rags and pRK5–HA–GATOR2 (ref. 30) were used. Other
hSesn2-mutants were generated by site-directed mutagenesis of wild-type
hSesn2 complementary DNA and subcloned into the pLU-CMV–Flag plasmid.
Lentiviruses were generated from the corresponding pLU constructs at the UM
Vector Core. For exogenous protein expression, HEK293 cells were transfected
with puriﬁed plasmid constructs and polyethylenimine (PEI, Sigma)67
or infected with replication-deﬁcient lentiviral particles68. Cells were harvested
2 days after treatments for immunoblotting or immunoprecipitation
experiments.
Immunoprecipitation and immunoblotting. Cell and tissue lysates were prepared
in a lysis buffer4 containing 0.3% CHAPS and protease inhibitor cocktail (Roche),
and immunoprecipitated with anti-HA (A2095, Sigma) or anti-Flag (A2220,
Sigma) agarose bead or hSesn2 antibody (8487, Cell Signaling, 1:100) conjugated to
a protein G/A bead (Calbiochem). The beads were then washed four times with the
lysis buffer. Whole cell lysates and the puriﬁed immunocomplexes were boiled in
SDS sample buffer for 5 min, separated by SDS–PAGE, transferred to PVDF
membranes and probed with indicated primary antibodies. HA (3F10, Roche,
1:1,000), Flag (M2, Sigma, 1:1,000), Actin (9E10, Developmental Studies
Hybridoma Bank, 1:100), phospho-Thr389-S6K (9234, Cell Signaling, 1:1,000),
pThr172-AMPK (2535, Cell Signaling, 1:1,000), pThr37/46 4E-BP (2855, Cell
Signaling, 1:1,000), 4E-BP (9452, Cell Signaling, 1:1,000), phospho-Ser236/239-S6
(2211, Cell Signaling, 1:1,000), S6 (2317, Cell Signaling, 1:1,000), S6K (sc-230, Santa
Cruz Biotechnology, 1:100), AMPK (sc-25792, Santa Cruz Biotechnology, 1:100)
and hSesn2 (10795-1-AP, Proteintech, 1:1,000) antibodies were used for
immunoblotting experiments. After incubation with secondary antibodies
conjugated with horseradish peroxidase (Bio-Rad), chemiluminescence was
detected using X-ray ﬁlms or a LAS4000 (GE) system69. Uncropped images of
immunoblots are provided in Supplementary Fig. 10.
In vitro pull-down assay. HA–GATOR2 or Flag–hSesn2 (WT, C125S, D406A or
D407A)-transfected HEK293 cell lysates were prepared in a lysis buffer containing
0.3% CHAPS and protease inhibitor cocktail, and immunopuriﬁed with anti-HA
(A2095) or anti-Flag (A2220) agarose bead. The Flag–Sesn2 was then washed four
times with the lysis buffer and eluted from the beads using Flag peptide (F3290,
Sigma). For the pull-down assays, the anti-HA–GATOR2 immunocomplexes
were washed four times with the lysis buffer and incubated overnight with puriﬁed
Flag–hSesn2 proteins of WT, C125S, D406A or D407A at 4 °C. After extensive
washing, the HA–GATOR2 complexes were eluted using HA peptide (I2149,
Sigma). The pull-down eluates, as well as inputs were analysed through
immunoblotting.
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